Clinically available RNA profiling tests of prostate tumors: utility and comparison

In the postscreening era, physicians are in need of methods to discriminate aggressive from nonaggressive prostate cancer (PCa) to reduce overdiagnosis and overtreatment. However, studies have shown that prognoses (e.g., progression and mortality) differ even among individuals with similar clinical...

Full description

Bibliographic Details
Main Authors: Rong Na, Yishuo Wu, Qiang Ding, Jianfeng Xu
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2016-01-01
Series:Asian Journal of Andrology
Subjects:
Online Access:http://www.ajandrology.com/article.asp?issn=1008-682X;year=2016;volume=18;issue=4;spage=575;epage=579;aulast=Na